biote Corp. (BTMD) Tops Q4 EPS by 11c, Revenue In Line; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024 4:05 PM EDTGrew practitioner network to over 7,100 from 6,400 in 2022
Launched BioteRx, our new hormone and therapeutic wellness offerings
Enhancing shareholder value with agreement to repurchase 18.4M founders shares in addition to a separate $20M share repurchase program
Reaffirms 2024 financial guidance, with an acceleration in second half growth



